Logo image of PFPT

Proofpoint Inc (PFPT) Stock Fundamental Analysis

NASDAQ:PFPT - Nasdaq -

175.9  -0.04 (-0.02%)

After market: 175.91 +0.01 (+0.01%)

Fundamental Rating

3

PFPT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. The financial health of PFPT is average, but there are quite some concerns on its profitability. PFPT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PFPT was profitable.

1.2 Ratios

Industry RankSector Rank
ROA -6.87%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -11.6%
PM (TTM) -15.16%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

5

2. Health

2.1 Basic Checks

There is no outstanding debt for PFPT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

PFPT has an Altman-Z score of 2.57. This is not the best score and indicates that PFPT is in the grey zone with still only limited risk for bankruptcy at the moment.
There is no outstanding debt for PFPT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.57
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.37 indicates that PFPT should not have too much problems paying its short term obligations.
A Quick Ratio of 1.37 indicates that PFPT should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37

More info and screens

8

3. Growth

3.1 Past

PFPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.84%, which is quite good.
Measured over the past years, PFPT shows a very strong growth in Earnings Per Share. The EPS has been growing by 55.54% on average per year.
Looking at the last year, PFPT shows a quite strong growth in Revenue. The Revenue has grown by 16.27% in the last year.
The Revenue has been growing by 31.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)16.84%
EPS 3Y33.84%
EPS 5Y55.54%
EPS Q2Q%23.53%
Revenue 1Y (TTM)16.27%
Revenue growth 3Y26.42%
Revenue growth 5Y31.66%
Sales Q2Q%19.43%

3.2 Future

PFPT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.44% yearly.
Based on estimates for the next years, PFPT will show a quite strong growth in Revenue. The Revenue will grow by 15.32% on average per year.
EPS Next Y16.1%
EPS Next 2Y17.24%
EPS Next 3Y15.17%
EPS Next 5Y11.44%
Revenue Next Year18.38%
Revenue Next 2Y18.01%
Revenue Next 3Y16.1%
Revenue Next 5Y15.32%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PFPT Yearly Revenue VS EstimatesPFPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
PFPT Yearly EPS VS EstimatesPFPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2 3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 79.23, the valuation of PFPT can be described as expensive.
When comparing the Price/Earnings ratio of PFPT to the average of the S&P500 Index (29.62), we can say PFPT is valued expensively.
PFPT is valuated quite expensively with a Price/Forward Earnings ratio of 64.31.
PFPT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 79.23
Fwd PE 64.31
PFPT Price Earnings VS Forward Price EarningsPFPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 108.23
PFPT Per share dataPFPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PFPT does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as PFPT's earnings are expected to grow with 15.17% in the coming years.
PEG (NY)4.92
PEG (5Y)1.43
EPS Next 2Y17.24%
EPS Next 3Y15.17%

More info and screens

0

5. Dividend

5.1 Amount

PFPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Proofpoint Inc

NASDAQ:PFPT (8/30/2021, 8:56:08 PM)

After market: 175.91 +0.01 (+0.01%)

175.9

-0.04 (-0.02%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)03-01 2022-03-01/amc
Inst Owners1.18%
Inst Owner Change0%
Ins Owners0.14%
Ins Owner Change0%
Market Cap10.16B
Analysts67.2
Price Target172.47 (-1.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 79.23
Fwd PE 64.31
P/S 8.93
P/FCF N/A
P/OCF N/A
P/B 35.72
P/tB N/A
EV/EBITDA 108.23
EPS(TTM)2.22
EY1.26%
EPS(NY)2.74
Fwd EY1.56%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS19.71
BVpS4.92
TBVpSN/A
PEG (NY)4.92
PEG (5Y)1.43
Profitability
Industry RankSector Rank
ROA -6.87%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -11.6%
PM (TTM) -15.16%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 2.57
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.84%
EPS 3Y33.84%
EPS 5Y55.54%
EPS Q2Q%23.53%
EPS Next Y16.1%
EPS Next 2Y17.24%
EPS Next 3Y15.17%
EPS Next 5Y11.44%
Revenue 1Y (TTM)16.27%
Revenue growth 3Y26.42%
Revenue growth 5Y31.66%
Sales Q2Q%19.43%
Revenue Next Year18.38%
Revenue Next 2Y18.01%
Revenue Next 3Y16.1%
Revenue Next 5Y15.32%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A